FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 2233656 · Received September 2, 2011

Report

Report Number
6000001-2011-22549
Event Type
Malfunction
Date Received
September 2, 2011
Date of Event
August 1, 2011
Report Date
August 12, 2011
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
MEB
PMA / PMN Number
K041738
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

(B)(4) ADDITIONAL INFORMATION: THE BATCH REVIEW REVEALED THAT ALL OF THE ACCEPTANCE CRITERIA WERE MET TO RELEASE THE LOT. THERE WERE NO NON-CONFORMANCES, FAILURES, REWORK, OR DEVIATIONS RELATED TO THE LOT. THERE WERE NO CHANGES TO SPECIFICATIONS, TEST METHODS, PROCESS, EQUIPMENT, OR RAW MATERIALS THAT COULD BE ASSOCIATED WITH THE REPORTED CONDITION. A LABELING REVIEW FOUND THE DIRECTIONS FOR USE: MIXING AND USE ADEQUATE FOR THE USE/USER ERROR IDENTIFIED IN THIS INCIDENT.

Additional Manufacturer Narrative · 1

(B)(4). PER THE CUSTOMER, THIS DEVICE IS NOT AVAILABLE FOR EVALUATION. THEREFORE, THE REPORTED CONDITION COULD NOT BE CONFIRMED AND THE ROOT CAUSE COULD NOT BE DETERMINED. SHOULD THE DEVICE AND/OR ANY ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

THE FACILITY REPORTED VIA PHONE THAT AN INFUSOR UNDERINFUSED DURING PATIENT USE. A VOLUME OF APPROXIMATELY 100 ML WAS INFUSED OVER THE COURSE OF 48 HOURS RATHER THAN 24 HOURS. THIS IMPLIES A 2.1 ML/HR FLOWRATE, WHICH IS 42% OF THE EXPECTED FLOWRATE. THE DEVICE WAS FILLED WITH A PRE-COMPOUNDED SOLUTION OF 0.1% ROPIVACAINE IN SALINE MANUFACTURED BY PHARMEDIUM. INFUSION FLOW RATE LESS THAN 70% OF EXPECTED RATE COULD LEAD TO A SERIOUS INJURY. THERE WAS PATIENT INVOLVEMENT, BUT THERE WAS NO PATIENT INJURY, MEDICAL INTERVENTION, OR ADVERSE REACTION IN ASSOCIATION WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE - IRVINE 11F018

Patients

Seq Age Sex Outcome Treatment
1 74 YR ROPIVACAINE